About: Elicio Therapeutics, Inc., a clinical-stage biotechnology company, develops immunotherapies for the treatment of cancer. Its lead product candidate, ELI-002, is a multivalent lymph node-targeted amphiphile (AMP) peptide vaccine that is in Phase II clinical trials for seven Kirsten rat sarcoma viral oncogene homolog driver mutations. The company also develops ELI-007, a multivalent lymph node-targeted AMP peptide treatment for mutant b-raf murine sarcoma viral oncogene homolog B1-(BRAF) driven cancers, and ELI-008, a multivalent lymph node-targeted AMP peptide vaccine in preclinical studies for the treatment of mutated tumor protein p53-expressing cancers. Elicio Therapeutics, Inc. is headquartered in Boston, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Latest price: $2.18 (-7.23%)
ELTXNASDAQElicio Therapeutics Inc.
Elicio Therapeutics Inc. share price
ELTX price activity
Last Price
$2.180
Change (24hr)
-0.17 USD (-7.23%)
Volume
456.43K
Volume (4w avg)
-
Open
$2.37
Day Range
$2.17 - $2.38
Previous Close
$2.35
Last Trade
09 Sep, 8:00 pm GMT+0
Delayed
09 Sep, 8:00 pm GMT+0
ELTX price performance
Delayed
09 Sep, 8:00 pm GMT+0
ELTX Market Signals